23/03/2026
Statin drugs, widely prescribed to lower cholesterol, have been linked to the alarming rise in dementia cases since their introduction in the late 1980s. According to Dr. Kevin Reese, dementia is directly correlated with the widespread use of statins. This is an inconvenient truth that many would prefer to ignore, especially those benefiting from the multi-billion-dollar pharmaceutical industry.
Dementia, including Alzheimer’s, saw a sharp increase in the 1990s, coinciding with the mass distribution of statins. These drugs, designed to lower cholesterol, have disrupted the body’s natural processes. Cholesterol, an essential component for brain function, is crucial for maintaining cognitive health. The statin-induced lowering of cholesterol is now being questioned by health experts as a major contributor to memory loss and cognitive decline.
The connection is clear: statins deprive the brain of essential cholesterol needed for proper function, and as a result, we see a disturbing spike in dementia. It's time to revisit the effectiveness and safety of statin drugs and understand the long-term effects on our health.
